Brief: Burning Rock Says Qtrly Loss Per Share $0.18
31/08/2023 06:36
Aug 31 (Reuters) - Burning Rock Biotech Ltd BNR.O :
* BURNING ROCK REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS
* QTRLY LOSS PER SHARE FOR CLASS A AND CLASS B ORDINARY
SHARES:
US$ 0.18
Source text for Eikon: ID:nGNXxjxNl
Further company coverage: BNR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Burning Rock Biotech
See all newsBurning Rock Biotech's Q2 revenue falls, net loss widens on central laboratory weakness
China's Burning Rock Biotech Q1 revenue falls on lower test volumes
China's Burning Rock Biotech Q4 net loss narrows as costs fall
Cancer diagnostics firm Burning Rock Biotech's Q3 revenue rises on pharma R&D growth
Brief: Burning Rock's Oncoguide™ Oncoscreen™ Plus CDX System Now Approved In Japan As A Companion Diagnostic For Capivasertib In Breast Cancer